SYSTAAQ Diagnostic Products Receives CE Mark for Molecular Diagnostics

SYSTAAQ Diagnostic Products (https://www.systaaq.com/) has announced today that it has received CE Mark for its HBV and HCV molecular diagnostic tests for the detection and quantitation of Hepatitis B and Hepatitis C viruses respectively. By achieving certification for these test, the Prince William Science Accelerator tenant, a Virginia-based firm, can sell these tests for clinical use across Europe and other geographies that recognize the designation.

SYSTAAQ Diagnostic Products is one of the leaders in molecular diagnostics, offering a wide range of products and services in the field of molecular testing. SYSTAAQ has developed highly sensitive and specific molecular diagnostic test for a number of infectious diseases. SYSTAAQ’s HBV and HCV Real Time PCR kits are molecular tests for detection and quantitation of Hepatitis B and Hepatitis viral loads by means of Real Time PCR.

Danial Richardson, Chairman Scientific Advisory Board at SYSTAAQ said that with high sensitivity and specificity of the tests, these tests can play a transformative role in the way healthcare providers diagnose the infections at a very early stage”. The tests will soon be launched in Europe, Asia and South America.

The following two tabs change content below.
Chris Frew
Over the past 8 years, Chris has grown BioBuzz into a respected brand that is recognized for its community building, networking events and news stories about the local biotech industry. In addition, he runs a Recruiting and Marketing Agency that helps companies attract top talent through a blended model that combines employer branding and marketing services together with a high powered recruiting solution.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.